By


MEBIAS Discovery LLC Presents Pre-Clinical Data on MU Opioid Receptor Pain Compounds at ADDC 

See more here

By


Intezyne Closes Oversubscribed $10M Series A Financing to Drive Rapid Oncology Portfolio Development 

See more here

By


Melior Pharmaceuticals Initiates Phase 2b Study with MLR-1023 for Type 2 Diabetes 

See more here

By


Opsidio Closes Bridge Financing to Develop Monoclonal Antibodies to Treat Fibrotic Diseases

See more here

By


VenatoRx Receives $9.4 Million from CARB-X to Develop a New Class of Antibiotic to Combat Multi-Drug Resistant Bacteria

See more here

By


VenatoRx Raises $42 Million Series B: Versant, Abingworth, Foresite Back Industry-Leading Antibiotics Developer

See more here